S&P 500   4,967.23
DOW   37,986.40
QQQ   414.65
North Carolina medical marijuana sales begin at Cherokee store
Ukrainian and Western leaders laud US aid package while the Kremlin warns of 'further ruin'
Biden sees a $35 price cap for insulin as a pivotal campaign issue. It’s not that clear-cut
Hawaii lawmakers take aim at vacation rentals after Lahaina wildfire amplifies Maui housing crisis
'Civil War’ continues box-office campaign at No. 1
Autoworkers union celebrates breakthrough win in Tennessee and takes aim at more plants in the South
Tens of thousands of Colombians protest against the leftist president's reform agenda
S&P 500   4,967.23
DOW   37,986.40
QQQ   414.65
North Carolina medical marijuana sales begin at Cherokee store
Ukrainian and Western leaders laud US aid package while the Kremlin warns of 'further ruin'
Biden sees a $35 price cap for insulin as a pivotal campaign issue. It’s not that clear-cut
Hawaii lawmakers take aim at vacation rentals after Lahaina wildfire amplifies Maui housing crisis
'Civil War’ continues box-office campaign at No. 1
Autoworkers union celebrates breakthrough win in Tennessee and takes aim at more plants in the South
Tens of thousands of Colombians protest against the leftist president's reform agenda
S&P 500   4,967.23
DOW   37,986.40
QQQ   414.65
North Carolina medical marijuana sales begin at Cherokee store
Ukrainian and Western leaders laud US aid package while the Kremlin warns of 'further ruin'
Biden sees a $35 price cap for insulin as a pivotal campaign issue. It’s not that clear-cut
Hawaii lawmakers take aim at vacation rentals after Lahaina wildfire amplifies Maui housing crisis
'Civil War’ continues box-office campaign at No. 1
Autoworkers union celebrates breakthrough win in Tennessee and takes aim at more plants in the South
Tens of thousands of Colombians protest against the leftist president's reform agenda
S&P 500   4,967.23
DOW   37,986.40
QQQ   414.65
North Carolina medical marijuana sales begin at Cherokee store
Ukrainian and Western leaders laud US aid package while the Kremlin warns of 'further ruin'
Biden sees a $35 price cap for insulin as a pivotal campaign issue. It’s not that clear-cut
Hawaii lawmakers take aim at vacation rentals after Lahaina wildfire amplifies Maui housing crisis
'Civil War’ continues box-office campaign at No. 1
Autoworkers union celebrates breakthrough win in Tennessee and takes aim at more plants in the South
Tens of thousands of Colombians protest against the leftist president's reform agenda
NYSEARCA:IJJ

iShares S&P Mid-Cap 400 Value ETF (IJJ) Price, Holdings, & News

$110.55
+1.09 (+1.00%)
(As of 04/19/2024 ET)
Today's Range
$109.23
$110.55
50-Day Range
$109.44
$118.29
52-Week Range
$92.79
$118.63
Volume
89,125 shs
Average Volume
165,532 shs
Market Capitalization
$7.36 billion
Assets Under Management
$7.14 billion
Dividend Yield
1.79%
Net Expense Ratio
0.18%
IJJ stock logo

About iShares S&P Mid-Cap 400 Value ETF (NYSEARCA:IJJ)

iShares S&P Mid-Cap 400 Value ETF, formerly iShares S&P MidCap 400 Value Index Fund (the Fund), is an exchange traded fund. The Fund seeks investment results that correspond generally to the price and yield performance of the S&P MidCap 400 Value Index (the Index). The Value Index measures the performance of the mid-capitalization value sector of the United States equity market and consists of those stocks in the S&P MidCap 400 Index exhibiting the strongest value characteristics. The Fund invests in a representative sample of securities included in the Index that collectively has an investment profile similar to the Index. The Index is a subset of the S&P 400 Index and consists of those companies exhibiting the strongest value characteristics within the S&P 400 Index, representing 53% approximately of the market capitalization of the Index. BlackRock Fund Advisors (BFA) serves as the investment adviser to the Fund.

IJJ Stock Price History

IJJ ETF News Headlines

iShares S&P Mid-Cap 400 Value ETF (IJJ)
Double your money before lunch?
Unlike bacterial infections, viral infections can be difficult to treat with medicine. Usually, if you've got a virus, your doctor's best advice is to simply rest and allow your immune system to fight back. Antiviral medications prevent viruses from reproducing, but they can't actually stop the virus. However, scientists may have just found a new way to fight back.
Sum Up The Parts: IJJ Could Be Worth $119
Analysts See 18% Gains Ahead For IJJ
Analysts Forecast 21% Gains Ahead For IJJ
Double your money before lunch?
Unlike bacterial infections, viral infections can be difficult to treat with medicine. Usually, if you've got a virus, your doctor's best advice is to simply rest and allow your immune system to fight back. Antiviral medications prevent viruses from reproducing, but they can't actually stop the virus. However, scientists may have just found a new way to fight back.
Surprising Analyst 12-Month Target For IJJ
See More Headlines
Receive IJJ Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for iShares S&P Mid-Cap 400 Value ETF and its competitors with MarketBeat's FREE daily newsletter.

Fund Details

Issuer
iShares
Fund Name
iShares S&P Mid-Cap 400 Value ETF
Tax Classification
Regulated Investment Company
Current Symbol
NYSEARCA:IJJ
Inception Date
7/24/2000
Fund Manager
Diane Hsiung, Jennifer Hsui, Greg Savage, Alan Mason

Fund Focus

Asset Class
Equity
Benchmark
S&P MidCap 400(R) Value Index
Category
Size and Style
Focus
Mid Cap
Development Level
Developed Markets
Region
North America
Number of Holdings
307

Fund Statistics

Assets Under Management
$7.14 billion
Average Daily Volume
$110,200.50
Discount/Premium
0.00%

Administrator, Advisor and Custodian

Administrator
JPMorgan Chase Bank, N.A.
Advisor
BlackRock Fund Advisors
Custodian
JPMorgan Chase Bank, N.A.
Distributor
BlackRock Investments, LLC
Transfer Agent
JPMorgan Chase Bank, N.A.
Trustee
N/A
Lead Market Maker
Latour Trading

Options

Optionable
Optionable
Options Volume
1
Put Options
1
Call Options
2
Short Interest
46,300 shs

Miscellaneous

Beta
1.17
Creation Unit
50,000
Creation Fee
$515.00
Ten Starter Stocks For Beginners to Buy Now Cover

Just getting into the stock market? These 10 simple stocks can help beginning investors build long-term wealth without knowing options, technicals, or other advanced strategies.

Get This Free Report

iShares S&P Mid-Cap 400 Value ETF Expenses

TypeIJJMid Cap ETFsEquity ETFsNYSEARCA ETFsAll ETFs
Management Fee0.18%0.34%0.54%0.50%0.51%
Other Expenses0.00%0.36%0.54%0.64%0.58%
Total Expense0.18%0.46%0.70%0.74%0.70%
Fee Waiver0.00%-0.46%-0.55%-0.68%-0.57%
Net Expense0.18%0.37%0.60%0.58%0.58%

iShares S&P Mid-Cap 400 Value ETF (IJJ) Holdings & Exposure

IJJ Sector Exposure

IJJ Industry Exposure

Key Executives

  • George G. C. Parker Ph.D. (Age 78)
    Independent Chairman of the Board of Trustees
  • Michael Arthur Latham (Age 51)
    President, Trustee
  • Jack Gee (Age 57)
    Chief Financial Officer, Treasurer
  • Geoffrey D. Flynn
    Chief Operating Officer, Executive Vice President
  • Amy Schioldager (Age 56)
    Executive Vice President
  • Ira P. Shapiro (Age 52)
    Vice President, Chief Legal Officer
  • Matt Tucker
    Vice President
  • Eilleen M. Clavere (Age 61)
    Secretary
  • John E. Kerrigan (Age 61)
    Independent Director
  • Cecilia H. Herbert (Age 68)
    Independent Trustee

IJJ ETF - Frequently Asked Questions

How have IJJ shares performed in 2024?

iShares S&P Mid-Cap 400 Value ETF's stock was trading at $114.04 on January 1st, 2024. Since then, IJJ stock has decreased by 3.1% and is now trading at $110.55.
View the best growth stocks for 2024 here
.

What does IJJ invest in?

iShares S&P Mid-Cap 400 Value ETF is a equity fund issued by iShares. IJJ focuses on mid cap investments and follows the S&P MidCap 400(R) Value Index. The fund's investments total to approximately $7.14 billion assets under management.

What stocks does iShares S&P Mid-Cap 400 Value ETF hold?
What is the management fee for iShares S&P Mid-Cap 400 Value ETF?

iShares S&P Mid-Cap 400 Value ETF's management fee is 0.18% and has no other recorded expenses or fee waivers. The net expense ratio for IJJ is 0.18%.

When did iShares S&P Mid-Cap 400 Value ETF's stock split?

iShares S&P Mid-Cap 400 Value ETF shares split on Monday, October 19th 2020. The 2-1 split was announced on Friday, September 18th 2020. The newly created shares were distributed to shareholders after the market closes on Friday, October 16th 2020. An investor that had 100 shares of stock prior to the split would have 200 shares after the split.

What other stocks do shareholders of iShares S&P Mid-Cap 400 Value ETF own?

Based on aggregate information from My MarketBeat watchlists, some companies that other iShares S&P Mid-Cap 400 Value ETF investors own include CVS Health (CVS), Pfizer (PFE), Cisco Systems (CSCO), iShares Core S&P Small-Cap ETF (IJR), NVIDIA (NVDA), AT&T (T), Verizon Communications (VZ), Exxon Mobil (XOM), Alibaba Group (BABA) and Enterprise Products Partners (EPD).

Who are iShares S&P Mid-Cap 400 Value ETF's major shareholders?

iShares S&P Mid-Cap 400 Value ETF's stock is owned by a variety of institutional and retail investors. Top institutional shareholders include Evensky & Katz LLC (0.91%), Willis Johnson & Associates Inc. (0.62%), Courier Capital LLC (0.32%), Capital Advisors Ltd. LLC (0.19%), Ellis Investment Partners LLC (0.16%) and Wealth Enhancement Advisory Services LLC (0.16%).

How do I buy shares of iShares S&P Mid-Cap 400 Value ETF?

Shares of IJJ stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (NYSEARCA:IJJ) was last updated on 4/21/2024 by MarketBeat.com Staff

From Our Partners